⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 20/02/23 | 16:35:22 | 20 Feb 2023 | Price Monitoring Extension | |
| 15/02/23 | 07:00:05 | 15 Feb 2023 | Investor presentation | |
| 13/02/23 | 14:05:30 | 13 Feb 2023 | Second Price Monitoring Extn | |
| 13/02/23 | 14:00:14 | 13 Feb 2023 | Price Monitoring Extension | |
| 13/02/23 | 11:05:32 | 13 Feb 2023 | Second Price Monitoring Extn | |
| 13/02/23 | 11:00:21 | 13 Feb 2023 | Price Monitoring Extension | |
| 13/02/23 | 09:05:42 | 13 Feb 2023 | Second Price Monitoring Extn | |
| 13/02/23 | 09:00:24 | 13 Feb 2023 | Price Monitoring Extension | |
| 13/02/23 | 07:00:05 | 13 Feb 2023 | Company Update | |
| 01/02/23 | 16:40:57 | 1 Feb 2023 | Second Price Monitoring Extn | |
| 01/02/23 | 16:35:29 | 1 Feb 2023 | Price Monitoring Extension | |
| 01/02/23 | 16:25:03 | 1 Feb 2023 | FDA grants New Chemical Entity designation | |
| 27/01/23 | 07:00:05 | 27 Jan 2023 | Block listing six monthly return | |
| 28/12/22 | 09:05:49 | 28 Dec 2022 | Second Price Monitoring Extn | |
| 28/12/22 | 09:00:33 | 28 Dec 2022 | Price Monitoring Extension | |
| 28/12/22 | 07:00:08 | 28 Dec 2022 | FDA Approves XENOVIEW™ (Xe 129 hyperpolarized) | |
| 03/10/22 | 11:05:38 | 3 Oct 2022 | Second Price Monitoring Extn | |
| 03/10/22 | 11:00:25 | 3 Oct 2022 | Price Monitoring Extension | |
| 30/09/22 | 07:00:17 | 30 Sept 2022 | Update on New Drug Application | |
| 22/09/22 | 14:05:57 | 22 Sept 2022 | Second Price Monitoring Extn | |
| 22/09/22 | 14:00:46 | 22 Sept 2022 | Price Monitoring Extension | |
| 22/09/22 | 11:06:05 | 22 Sept 2022 | Second Price Monitoring Extn | |
| 22/09/22 | 11:00:36 | 22 Sept 2022 | Price Monitoring Extension | |
| 22/09/22 | 09:05:58 | 22 Sept 2022 | Second Price Monitoring Extn | |
| 22/09/22 | 09:00:49 | 22 Sept 2022 | Price Monitoring Extension | |
| 22/09/22 | 07:04:58 | 22 Sept 2022 | Update on New Drug Application | |
| 31/08/22 | 07:00:02 | 31 Aug 2022 | Half-year Report | |
| 26/08/22 | 07:00:05 | 26 Aug 2022 | Directorate appointment | |
| 04/08/22 | 16:40:44 | 4 Aug 2022 | Second Price Monitoring Extn | |
| 04/08/22 | 16:35:52 | 4 Aug 2022 | Price Monitoring Extension | |
| 28/07/22 | 07:00:06 | 28 Jul 2022 | Total voting rights and block listing return | |
| 08/07/22 | 07:00:06 | 8 Jul 2022 | System delivery | |
| 29/06/22 | 16:35:35 | 29 Jun 2022 | Result of AGM | |
| 18/05/22 | 07:00:05 | 18 May 2022 | Final Results | |
| 11/05/22 | 07:00:05 | 11 May 2022 | Notice of Results | |
| 11/05/22 | 07:00:03 | 11 May 2022 | Oxford research collaboration in long COVID | |
| 05/05/22 | 07:00:06 | 5 May 2022 | Directorate Change | |
| 29/04/22 | 07:00:02 | 29 Apr 2022 | Total Voting Rights | |
| 25/04/22 | 07:00:07 | 25 Apr 2022 | New system order | |
| 20/04/22 | 07:00:03 | 20 Apr 2022 | New Drug Application Resubmission update | |
| 14/04/22 | 07:00:06 | 14 Apr 2022 | Appointment of Non-Executive Director | |
| 08/04/22 | 07:00:02 | 8 Apr 2022 | Exercise of Options and Total Voting Rights | |
| 31/03/22 | 14:05:52 | 31 Mar 2022 | Second Price Monitoring Extn | |
| 31/03/22 | 14:00:56 | 31 Mar 2022 | Price Monitoring Extension | |
| 31/03/22 | 11:06:08 | 31 Mar 2022 | Second Price Monitoring Extn | |
| 31/03/22 | 11:00:32 | 31 Mar 2022 | Price Monitoring Extension | |
| 31/03/22 | 09:00:43 | 31 Mar 2022 | Price Monitoring Extension | |
| 31/03/22 | 07:00:08 | 31 Mar 2022 | New Drug Application Resubmission | |
| 25/02/22 | 07:00:05 | 25 Feb 2022 | Total Voting Rights | |
| 14/02/22 | 07:00:07 | 14 Feb 2022 | New system order |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 20/02/23 | 16:35:22 | 20 Feb 2023 | Price Monitoring Extension | |
| 15/02/23 | 07:00:05 | 15 Feb 2023 | Investor presentation | |
| 13/02/23 | 14:05:30 | 13 Feb 2023 | Second Price Monitoring Extn | |
| 13/02/23 | 14:00:14 | 13 Feb 2023 | Price Monitoring Extension | |
| 13/02/23 | 11:05:32 | 13 Feb 2023 | Second Price Monitoring Extn | |
| 13/02/23 | 11:00:21 | 13 Feb 2023 | Price Monitoring Extension | |
| 13/02/23 | 09:05:42 | 13 Feb 2023 | Second Price Monitoring Extn | |
| 13/02/23 | 09:00:24 | 13 Feb 2023 | Price Monitoring Extension | |
| 13/02/23 | 07:00:05 | 13 Feb 2023 | Company Update | |
| 01/02/23 | 16:40:57 | 1 Feb 2023 | Second Price Monitoring Extn | |
| 01/02/23 | 16:35:29 | 1 Feb 2023 | Price Monitoring Extension | |
| 01/02/23 | 16:25:03 | 1 Feb 2023 | FDA grants New Chemical Entity designation | |
| 27/01/23 | 07:00:05 | 27 Jan 2023 | Block listing six monthly return | |
| 28/12/22 | 09:05:49 | 28 Dec 2022 | Second Price Monitoring Extn | |
| 28/12/22 | 09:00:33 | 28 Dec 2022 | Price Monitoring Extension | |
| 28/12/22 | 07:00:08 | 28 Dec 2022 | FDA Approves XENOVIEW™ (Xe 129 hyperpolarized) | |
| 03/10/22 | 11:05:38 | 3 Oct 2022 | Second Price Monitoring Extn | |
| 03/10/22 | 11:00:25 | 3 Oct 2022 | Price Monitoring Extension | |
| 30/09/22 | 07:00:17 | 30 Sept 2022 | Update on New Drug Application | |
| 22/09/22 | 14:05:57 | 22 Sept 2022 | Second Price Monitoring Extn | |
| 22/09/22 | 14:00:46 | 22 Sept 2022 | Price Monitoring Extension | |
| 22/09/22 | 11:06:05 | 22 Sept 2022 | Second Price Monitoring Extn | |
| 22/09/22 | 11:00:36 | 22 Sept 2022 | Price Monitoring Extension | |
| 22/09/22 | 09:05:58 | 22 Sept 2022 | Second Price Monitoring Extn | |
| 22/09/22 | 09:00:49 | 22 Sept 2022 | Price Monitoring Extension | |
| 22/09/22 | 07:04:58 | 22 Sept 2022 | Update on New Drug Application | |
| 31/08/22 | 07:00:02 | 31 Aug 2022 | Half-year Report | |
| 26/08/22 | 07:00:05 | 26 Aug 2022 | Directorate appointment | |
| 04/08/22 | 16:40:44 | 4 Aug 2022 | Second Price Monitoring Extn | |
| 04/08/22 | 16:35:52 | 4 Aug 2022 | Price Monitoring Extension | |
| 28/07/22 | 07:00:06 | 28 Jul 2022 | Total voting rights and block listing return | |
| 08/07/22 | 07:00:06 | 8 Jul 2022 | System delivery | |
| 29/06/22 | 16:35:35 | 29 Jun 2022 | Result of AGM | |
| 18/05/22 | 07:00:05 | 18 May 2022 | Final Results | |
| 11/05/22 | 07:00:05 | 11 May 2022 | Notice of Results | |
| 11/05/22 | 07:00:03 | 11 May 2022 | Oxford research collaboration in long COVID | |
| 05/05/22 | 07:00:06 | 5 May 2022 | Directorate Change | |
| 29/04/22 | 07:00:02 | 29 Apr 2022 | Total Voting Rights | |
| 25/04/22 | 07:00:07 | 25 Apr 2022 | New system order | |
| 20/04/22 | 07:00:03 | 20 Apr 2022 | New Drug Application Resubmission update | |
| 14/04/22 | 07:00:06 | 14 Apr 2022 | Appointment of Non-Executive Director | |
| 08/04/22 | 07:00:02 | 8 Apr 2022 | Exercise of Options and Total Voting Rights | |
| 31/03/22 | 14:05:52 | 31 Mar 2022 | Second Price Monitoring Extn | |
| 31/03/22 | 14:00:56 | 31 Mar 2022 | Price Monitoring Extension | |
| 31/03/22 | 11:06:08 | 31 Mar 2022 | Second Price Monitoring Extn | |
| 31/03/22 | 11:00:32 | 31 Mar 2022 | Price Monitoring Extension | |
| 31/03/22 | 09:00:43 | 31 Mar 2022 | Price Monitoring Extension | |
| 31/03/22 | 07:00:08 | 31 Mar 2022 | New Drug Application Resubmission | |
| 25/02/22 | 07:00:05 | 25 Feb 2022 | Total Voting Rights | |
| 14/02/22 | 07:00:07 | 14 Feb 2022 | New system order |